Consolidated Statement Of Cash Flows

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7600343

Concept 2021-04-01 to
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2020-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
13,885,000,000 JPY
14,209,000,000 JPY
18,657,000,000 JPY
18,613,000,000 JPY
Depreciation
2,481,000,000 JPY
2,318,000,000 JPY
Impairment losses
2,994,000,000 JPY
JPY
Amortization of goodwill
5,000,000 JPY
JPY
Interest and dividend income
-397,000,000 JPY
-393,000,000 JPY
Interest expenses
17,000,000 JPY
17,000,000 JPY
Increase (decrease) in retirement benefit liability
-44,000,000 JPY
239,000,000 JPY
Loss (gain) on sale of property, plant and equipment
-195,000,000 JPY
-379,000,000 JPY
Subtotal
17,387,000,000 JPY
19,521,000,000 JPY
Decrease (increase) in trade receivables
392,000,000 JPY
1,251,000,000 JPY
Decrease (increase) in inventories
241,000,000 JPY
-2,923,000,000 JPY
Increase (decrease) in trade payables
-2,630,000,000 JPY
-112,000,000 JPY
Net cash provided by (used in) operating activities
13,336,000,000 JPY
14,380,000,000 JPY
Other, net
542,000,000 JPY
915,000,000 JPY
Interest and dividends received
397,000,000 JPY
393,000,000 JPY
Interest paid
-17,000,000 JPY
-17,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-2,986,000,000 JPY
-1,973,000,000 JPY
Proceeds from sale of property, plant and equipment
704,000,000 JPY
874,000,000 JPY
Purchase of investment securities
JPY
-20,000,000 JPY
Net cash provided by (used in) investing activities
-7,888,000,000 JPY
-1,644,000,000 JPY
Proceeds from sale of investment securities
5,000,000 JPY
144,000,000 JPY
Purchase of shares of subsidiaries resulting in change in scope of consolidation
-4,975,000,000 JPY
JPY
Other, net
-365,000,000 JPY
-357,000,000 JPY
Cash flows from financing activities
Dividends paid
-5,714,000,000 JPY
-5,811,000,000 JPY
Net cash provided by (used in) financing activities
-8,129,000,000 JPY
-8,752,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
JPY
JPY
Net increase (decrease) in cash and cash equivalents
-2,680,000,000 JPY
3,983,000,000 JPY
Cash and cash equivalents
74,625,000,000 JPY
77,305,000,000 JPY
73,322,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.